Dingdang Health trims float with 105,000-share buyback; 14.34 million shares awaiting cancellation

Bulletin Express07-14

Dingdang Health Technology Group Ltd. (HKEX: 09886) reported a fresh share repurchase on 14 July 2026, acquiring 105,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.92 and HKD 0.94, for a volume-weighted average of HKD 0.9343. The transaction cost totalled HKD 0.10 million, and the shares have been transferred to the company’s treasury stock.

Following the latest buyback, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1,254.07 million, while treasury shares rose to 0.58 million. The company’s total issued share capital remains unchanged at 1,254.65 million shares.

Under the repurchase mandate granted on 23 June 2026, the company has so far repurchased 3.44 million shares—equivalent to 0.28 % of the issued share base on the mandate date. A 30-day moratorium on new share issues or treasury share sales is in force until 13 August 2026.

In addition, 14.34 million shares bought back between 19 May and 8 July 2026 are still pending formal cancellation, representing roughly 1.14 % of the current issued shares. Repurchase prices for these shares ranged from HKD 0.83 to HKD 0.97.

The board confirms that all repurchases were conducted in accordance with Hong Kong Stock Exchange listing rules and relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156250463?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 18:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156250463","market":"hk","top_or_hot":-1,"title":"Dingdang Health trims float with 105,000-share buyback; 14.34 million shares awaiting cancellation","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (HKEX: 09886) reported a fresh share repurchase on 14 July 2026, acquiring 105,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.92 and HKD 0.94, for a volume-weighted average of HKD 0.9343. The transaction cost totalled HKD 0.10 million, and the shares have been transferred to the company’s treasury stock.</p>\n<p>Following the latest buyback, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1,254.07 million, while treasury shares rose to 0.58 million. The company’s total issued share capital remains unchanged at 1,254.65 million shares.</p>\n<p>Under the repurchase mandate granted on 23 June 2026, the company has so far repurchased 3.44 million shares—equivalent to 0.28 % of the issued share base on the mandate date. A 30-day moratorium on new share issues or treasury share sales is in force until 13 August 2026.</p>\n<p>In addition, 14.34 million shares bought back between 19 May and 8 July 2026 are still pending formal cancellation, representing roughly 1.14 % of the current issued shares. Repurchase prices for these shares ranged from HKD 0.83 to HKD 0.97.</p>\n<p>The board confirms that all repurchases were conducted in accordance with Hong Kong Stock Exchange listing rules and relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health trims float with 105,000-share buyback; 14.34 million shares awaiting cancellation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health trims float with 105,000-share buyback; 14.34 million shares awaiting cancellation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-14 18:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (HKEX: 09886) reported a fresh share repurchase on 14 July 2026, acquiring 105,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.92 and HKD 0.94, for a volume-weighted average of HKD 0.9343. The transaction cost totalled HKD 0.10 million, and the shares have been transferred to the company’s treasury stock.</p>\n<p>Following the latest buyback, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1,254.07 million, while treasury shares rose to 0.58 million. The company’s total issued share capital remains unchanged at 1,254.65 million shares.</p>\n<p>Under the repurchase mandate granted on 23 June 2026, the company has so far repurchased 3.44 million shares—equivalent to 0.28 % of the issued share base on the mandate date. A 30-day moratorium on new share issues or treasury share sales is in force until 13 August 2026.</p>\n<p>In addition, 14.34 million shares bought back between 19 May and 8 July 2026 are still pending formal cancellation, representing roughly 1.14 % of the current issued shares. Repurchase prices for these shares ranged from HKD 0.83 to HKD 0.97.</p>\n<p>The board confirms that all repurchases were conducted in accordance with Hong Kong Stock Exchange listing rules and relevant regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1156250463","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156250463","pubTimestamp":1784024514,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (HKEX: 09886) reported a fresh share repurchase on 14 July 2026, acquiring 105,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.92 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康通过回购 105,000 股股票削减流通股；1434万股等待注销","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (HKEX: 09886) reported a fresh share repurchase on 14 July 2026, acquiring 105,000 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 0.92 and HKD 0.94, for a volume-weighted average of HKD 0.9343. The transaction cost totalled HKD 0.10 million, and the shares have been transferred to the company’s treasury stock.\nFollowing the latest buyback, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1,254.07 million, while treasury shares rose to 0.58 million. The company’s total issued share capital remains unchanged at 1,254.65 million shares.\nUnder the repurchase mandate granted on 23 June 2026, the company has so far repurchased 3.44 million shares—equivalent to 0.28 % of the issued share base on the mandate date. A 30-day moratorium on new share issues or treasury share sales is in force until 13 August 2026.\nIn addition, 14.34 million shares bought back between 19 May and 8 July 2026 are still pending formal cancellation, representing roughly 1.14 % of the current issued shares. Repurchase prices for these shares ranged from HKD 0.83 to HKD 0.97.\nThe board confirms that all repurchases were conducted in accordance with Hong Kong Stock Exchange listing rules and relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156250463","isCrawlerRequest":true}